We are thrilled to announce a novel endeavor in the field of veterinary medicine—the launch of Veterinary Oncology, a new scientific journal from the Springer Nature family.

In recent years, there has been a profound surge in the recognition of cancer as a significant health concern among our companion animals, as well as the value of comparative oncology as a valuable tool in cancer research. As our understanding of veterinary oncology deepens, so too does the need for a dedicated platform to disseminate cutting-edge research, share clinical insights, and foster collaboration among veterinary professionals and others working in cancer research worldwide. Veterinary Oncology emerges as a response to this need, poised to serve as a premier platform for scholarly discourse and innovation in veterinary cancer care.

At Veterinary Oncology we pledge to uphold the highest standards of scientific rigor and integrity in the peer review process. We are delighted and grateful that the journal is supported by an editorial board comprising experts from diverse disciplines within veterinary medicine, ensuring a breadth of perspectives and a wealth of knowledge and experience. Through a rigorous peer-review process, we endeavor to uphold the integrity of the research published in our journal and to publish content of high value to the community.

We welcome contributions that encompass a wide array of topics within veterinary oncology. From innovative therapeutic approaches, novel diagnostic modalities to cancer epidemiology and clinical case studies, and from basic science to translational research, Veterinary Oncology seeks to encompass the full spectrum of advancements in our field. Moreover, we recognize the vital role of interdisciplinary collaboration in tackling the complex challenges posed by cancer in animals. As such, Veterinary Oncology will serve as a bridge between various disciplines, fostering dialogue and collaboration among researchers, clinicians, and industry professionals.

In the first papers published this month, you will find new research pertaining to biomarkers of perfusion using histology and imaging techniques in dogs with head and neck cancers, as well as interesting new insight through a report of a synchronous canine meningioma and pituitary macroadenoma.

We invite you to join us in this endeavor, as we work together to shape the future of veterinary oncology.

With warm regards,

Amy LeBlanc & David Killick

Co-Editors-in-Chief, Veterinary Oncology